Tandem Diabetes Care, Inc. (TNDM)
18.46
+0.43
(+2.38%)
USD |
NASDAQ |
May 07, 16:00
20.60
+2.14
(+11.59%)
After-Hours: 20:00
Tandem Diabetes Care Research and Development Expense (Annual) : 174.84M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Insulet Corp. | 301.10M |
| Abbott Laboratories | 2.889B |
| ICU Medical, Inc. | 87.50M |
| iRhythm Holdings, Inc. | 84.61M |
| Beta Bionics, Inc. | 34.79M |